INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

70,589 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KJ
Kiviat JasonChief Financial Officer
TEADTeads Holding Co.
Tax withholding
F$1,788
2,129 sh
Mar 7, 2026Mar 10, 2026
Page 1173 of 1765
← PrevNext →
traded Mar 7, 2026
+3d
SEC Form 4

Evidence

9
LP
Lockwood-Taylor PatrickDirector, CEO
PRGOPERRIGO Co plc
Option exercise
M—
11.7K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Option exercise
M—
896 sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC Form 4

Evidence

9
HD
Hedigan DanielSee Remarks
FPHFive Point Holdings, LLC
Disposition to issuer
D—
74.5K sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

9
TK
Talluri Rajendra KDirector, President and CEO
ENVXEnovix Corp
Tax withholding
F$20K
4,109 sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC Form 4

Evidence

9
MR
Marion Tanya ReneeChief Human Resources Officer
EHABEnhabit, Inc.
Tax withholding
F$28K
2,058 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
SJ
Samuelson JonasDirector
PRGOPERRIGO Co plc
Option exercise
M$33K
3,066 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
2,625 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
JM
Jansen John MDirector
OKLOOklo Inc.
Option exercise
M—
16.9K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
DK
Davis KristaSVP, CHIEF HR OFFICER
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$111K
1,485 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
RD
Romaninsky Samuel DardenVP, General Counsel & CCO
NVRIENVIRI Corp
Tax withholding
F$20K
1,133 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
DD
DeLucia DavidChief Financial Officer
KYNBKYNTRA BIO, INC.
Tax withholding
F$410
60 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
LA
Lenz Robert A.Director
LBRXLB PHARMACEUTICALS INC
Grant or award
A—
20.0K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
KL
Kalvaitis Jeanne LouiseEVP of Hospice Operations
EHABEnhabit, Inc.
Tax withholding
F$11K
835 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
OD
Oddie Andrew DavidCHIEF INTERNATIONAL OFFICER
FNKOFunko, Inc.
Option exercise
M—
4,700 sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC Form 4

Evidence

9
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Grant or award
A—
83.2K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
GT
Garner ThomasEVP, Chief Commercial Officer
ACADACADIA PHARMACEUTICALS INC
Grant or award
A—
28.5K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
BW
Bradshaw WenkaiCAO & SVP Corporate Controller
TEADTeads Holding Co.
Tax withholding
F$90.72
108 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$490K
11.2K sh
Mar 10, 2026Mar 10, 2026
traded Mar 10, 2026
+0dSEC Form 4

Evidence

9
SJ
Samuelson JonasDirector
PRGOPERRIGO Co plc
Tax withholding
F$19K
1,748 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$314K
7,361 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

9
HD
Hedigan DanielSee Remarks
FPHFive Point Holdings, LLC
Option exercise
M—
98.7K sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

9
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
3,750 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
LM
Leon Justin MSVP, CORPORATE DEVELOPMENT
ATNIATN International, Inc.
Tax withholding
F$34K
1,424 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
CJ
Carlson Michael JamesPresident, Managed Services
STEMSTEM, INC.
Option exercise
M—
3,541 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
RR
Redfield RobertChief Medical Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
108.9K sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC Form 4

Evidence

9
NA
Narayanan ArunChief Executive Officer
STEMSTEM, INC.
Option exercise
M—
5,625 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
CJ
Comly Barbara J.EVP, GC & Corporate Secretary
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M—
16.7K sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

9
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
1,125 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

8
FC
Fruge Mary CelesteVP, General Counsel
NPKINPK International Inc.
Open-market sale · 10b5-1 plan
SELL$149K
11.2K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

7
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
25.0K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

6
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$110K
2,505 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

6
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$181K
4,441 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

6
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Grant or award
A—
29.9K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

5
MA
Morais Mark A.Chief Operating Officer
FTREFortrea Holdings Inc.
Grant or award
A—
66.7K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

5
FA
Fashinpaur Melissa AChief Accounting Officer
MTRNMATERION Corp
Grant or award
A—
2 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

5
LJ
Leite JohnChief Commercial Officer-CLIA
VCYTVERACYTE, INC.
Grant or award
A—
6,578 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

5
HB
Hammonds Kevin BCHIEF LEGAL OFFICER
FLRFLUOR CORP
Tax withholding
F$38K
845 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

5
SH
Shah HusnalChief Product Officer
FNKOFunko, Inc.
Option exercise
M—
2,344 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$1,185
463 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence